Arthex Biotech S.L. is a biotechnology company based in Paterna, Spain, that specializes in the development of antisense RNA therapies for genetic diseases. Founded in 2019 as a spin-off from the University of Valencia, the company focuses on addressing unmet medical needs through innovative treatments targeting microRNAs, which are implicated in various disorders, including neuromuscular diseases. With a team experienced in drug discovery and strong support from leading scientific and clinical advisors, Arthex Biotech aims to provide effective therapies for patients suffering from rare and challenging conditions.
Norbite is a biotech research firm focused on converting plastic waste into sustainable products through an innovative insect-based biorefinery. The company's technology integrates biorefinery and vertical farming methods to process plastic waste, yielding larvae that are bio-refined into proteins suitable for food and feed applications. By offering sustainable solutions, Norbite aims to contribute positively to environmental efforts while providing clients with valuable products and services.
nyris GmbH develops a visual product search platform. It serves companies across retail and e-commerce, industrial and manufacturing, media and entertainment, and financial services. The company was incorporated in 2015 and is based in Berlin, Germany with additional location in Dusseldorf.
Manufacturer of reusable containers intended to reduce waste. The company's container provides sealable and reusable packaging which works in tandem with electronic dispensers that are placed in shops for the distribution of food and non-food products in bulk, enabling producers and retailers to store and dispense products in hygienic ways.
Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in innovative cancer treatment through deep thermotherapy specifically targeting the head and neck region. As an Erasmus MC spinoff, the company focuses on developing novel hyperthermia techniques to enhance cancer care, providing a promising approach to improve treatment outcomes for patients suffering from tumors in these areas.
Voiseed is an AI-based company founded in 2020 and headquartered in Milan, Italy, specializing in the development of a virtual voice engine for speech synthesis. The company's software utilizes advanced generative AI technologies to replicate human emotions and prosody, creating highly expressive virtual voices. Voiseed's cloud-based platform offers a universal voice model and an emotional data set, allowing users to customize vocal expressions and perform multilingual voice conversions for various projects. This innovative tool enables creators in the dubbing industry to design voice textures that meet their specific requirements, significantly reducing costs, time, and complexity in the production process.
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, focused on developing genetically modified oncolytic viruses to improve cancer treatments. Established in 2013, the company aims to enhance tumor T-cell therapies through its patented technology, which utilizes oncolytic viruses to modify the tumor microenvironment and counteract its immune-suppressive properties. TILT Biotherapeutics is advancing several product candidates, including TILT-123, TILT-234, and TILT-321, and plans to translate its innovative approach into clinical trials. The technology is designed to bolster the effectiveness of tumor-infiltrating lymphocyte (TIL) therapies, chimeric antigen receptor (CAR-T) therapies, and checkpoint inhibitors, potentially achieving outcomes in solid tumors similar to those seen in hematological cancers.
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, focused on developing genetically modified oncolytic viruses to improve cancer treatments. Established in 2013, the company aims to enhance tumor T-cell therapies through its patented technology, which utilizes oncolytic viruses to modify the tumor microenvironment and counteract its immune-suppressive properties. TILT Biotherapeutics is advancing several product candidates, including TILT-123, TILT-234, and TILT-321, and plans to translate its innovative approach into clinical trials. The technology is designed to bolster the effectiveness of tumor-infiltrating lymphocyte (TIL) therapies, chimeric antigen receptor (CAR-T) therapies, and checkpoint inhibitors, potentially achieving outcomes in solid tumors similar to those seen in hematological cancers.
ReLearn is a startup focused on leveraging artificial intelligence to assist companies and municipalities in minimizing their environmental impact by monitoring waste production. Utilizing a plug-and-play sensor called NANDO, which is installed on trash bins, ReLearn gathers precise data on the quantity and quality of waste generated daily. This data facilitates the creation of detailed sustainability reports and enhances awareness of environmental issues among corporate and civic stakeholders. The company employs gamification techniques to engage users and promote environmentally responsible behaviors. ReLearn aims to support visionary organizations in achieving their ZERO WASTE goals and adhering to key Sustainable Development Goals. By transforming ordinary bins into smart waste management systems, ReLearn enables clients to automate processes and improve efficiency while reducing carbon emissions and operational costs associated with improper waste disposal. The company has garnered recognition for its innovative approach, being a winner of the European Social Innovation Competition in 2022.
Developer of an automated disassembly and diagnostics solutions to maximize the value of every Li-ion battery. The company's proprietary computer vision models and robotic systems allow the autonomous handling of batteries of all variations, its disassembly process preserves material value and help companies to capture significant upcycling potential for cells and components, disassembly is entirely manual owing to wide variety in battery designs and changing conditions. enabling customers save significant cost, see positive carbon impacts vs recycling and find a solution to increasing labor shortage.
SILEANE specialists of robotics and vision.
Blue Planet Ecosystems Incorporated, founded in 2018 and based in San Francisco, California, specializes in the development and operation of modular closed loop photo protein reactors aimed at sustainable food production in challenging environments. The company utilizes innovative technology to produce high-quality, pollutant-free fish, leveraging selected strains of green microalgae and advanced algorithms. By converting CO2 and sunlight into essential nutrients such as sugars, amino acids, and fatty acids, their systems create a sustainable food source for zooplankton and fish. This approach enables farmers and agricultural businesses to diversify their methods and adapt to the impacts of climate change and urbanization.
Developer of a forecasting software designed to forecast scientific understanding of hurricanes with computer vision and IoT technologies. The company's software utilizes the full resolution of satellite images to improve on conventional, numerical weather forecasting technology, enabling disaster managers to avoid or decrease the catastrophes related to hurricanes.
ATXA Therapeutics Limited is a pharmaceutical company based in Dublin, Ireland, focused on developing novel small molecule drugs for the treatment of pulmonary arterial hypertension (PAH). Established in 2015 as a spin-out from University College Dublin, the company has leveraged over 20 years of research and more than €15 million in grant funding to advance its clinical trials and secure marketing authorization for its therapies. ATXA's innovative approach involves targeting human thromboxane receptors to enhance vasodilation and reduce vasoconstriction, addressing significant unmet medical needs in PAH and other cardiovascular conditions. The team comprises experts in various fields, including cardiovascular and cancer biology, drug discovery, and preclinical pharmacokinetics, positioning ATXA to develop more effective treatments than current standard care options. The company aims to improve treatment outcomes for patients suffering from PAH and related conditions through its advanced therapies.
Tilkal is a Paris-based company founded in 2017 that specializes in developing a software platform for traceability across supply chains. Its end-to-end, real-time traceability solution integrates permissioned blockchain networks with big data to facilitate secure and verifiable data sharing among various supply chain stakeholders. The platform allows businesses to record traceability data of physical products in a ledger, enhancing compliance, transparency, and consumer trust. Tilkal's technology is actively utilized by major corporations such as Groupe Casino and Danone, providing them with the tools to analyze traceability data, manage sourcing risks, and demonstrate environmental, social, and governance (ESG) commitments. By focusing on resilience, sustainability, and ethical practices, Tilkal aims to improve the overall integrity of supply chains across diverse industries.
Beeodiversity is a company with a societal positif impact. Beeodiversity assists companies and local authorities to set up strategies and develop environmental projects generating added value for the environment, the partner and its stakeholders. It combines a scientific expertise, innovative tools based on nature and environmental coaching techniques.
Developer of an optical testing product intended for postoperative monitoring and treatment. The company's product makes the postoperative management of dislocated intraocular lenses intuitive and straightforward, enabling patients to reduce post-operative refractive issues after cataract surgery.
Releaf Paper is a producer of sustainable paper products from fallen leaves. They work on the task of finding a solution to achieve sustainability in the production of paper using new raw materials - fallen leaves, instead of wood.
Developer of a satellite maintenance platform intended to extend the operational lifetime of in-orbit GEO telecommunication satellites. The company's platform responds to challenges by offering a range of services based on software and computer technologies and provides sensors with situational awareness of their close environment, enabling space researchers to carry out autonomous navigation in orbit and provide reliable in-orbit services to satellite operators all over the world.
ELEM Biotech
Grant in 2022
ELEM is a start-up company conceived at the Barcelona Supercomputing Center (BSC) and host of MareNostrum supercomputer. ELEM is co-founded by BSC researchers Mariano Vázquez, Guillaume Houzeaux, José María Cela, and business consultant Chris Morton. The company has developed Alya Red, a set of simulation tools, which following a “Software-as-a-Service” model deployed in the cloud, focuses on medical devices and pharmaceutical industries. Alya Red simulates cardiovascular or respiratory systems on “virtual patients”. Combining high performance computing, computational biomechanics and data analysis, these computational avatars can be used by biomedical sector companies and clinicians to elaborate diagnoses, plan treatments, improve drug delivery and action, optimise medical devices, etc. ELEM headquarters are in Barcelona.
CYTO365 is the manufacturer of RondelO multi inlet stopcock, which is sold as a component aimed to be integrated into IV-set to combat Drug Incompatibility due to parallel infusion.
Aurora Propulsion Technologies Oy provides satellite manufacturers with highly reliable mass produced and high quality, components for attitude (orientation) and orbit control. The vision is to enable small (1- 15 kg) satellite manufacturers to be able to conduct their satellite missions effectively and take their satellites anywhere, be it to Low Earth orbit or other planets in the solar system.
Developer of autonomous greenhouse food production and indoor agriculture robots designed to automate tasks for food production in greenhouse horticulture sector industries. The company specializes in developing harvest and crop-handling robots and artificial intelligence-robotic harvester systems for indoor farming and eliminating factors like climate change and food security pressure, enabling farmers with a controlled climate and protection from the changes outside to get better yields with less land usage.
The Weed Whacker from Odd.Bot can be utilized via its Robot-as-a-Service offering and can be hired to clean any field of 10+ hectare. The intelligent robot -or robots- can detect both the weeds and crops already in an early stage and autonomously remove the weeds mechanically, specifically in the crop rows and in between the crops. Its biggest differentiators: sustainability: an alternative for (potential) harmful chemicals versatility: the spacing between the crops may vary resilience: it is highly adaptive and lightweight, which reduces soil compaction
Protinhi Therapeutics is a preclinical stage biotechnology company focused on developing antiviral drugs to combat various viral threats, including dengue, Zika, and COVID-19. The company's innovative approach utilizes proprietary technology and compounds that target viral diseases through protease inhibition. This mechanism disrupts the viruses' ability to replicate, providing healthcare providers with a means to effectively control the spread of these infections. By concentrating on significant public health challenges, Protinhi Therapeutics aims to contribute to global efforts in managing and mitigating viral outbreaks.
Tozero, founded in July 2022 in Munich, Germany, by Sarah Fleischer and Dr. Ksenija Milicevic Neumann, focuses on developing technology for recycling lithium-ion batteries. The company aims to create a scalable machine that recovers essential materials such as lithium, nickel, cobalt, graphite, and manganese in an environmentally sustainable manner. By facilitating the recovery of these critical materials, Tozero enables industries to reintegrate fresh raw materials back into the supply chain, thereby supporting broader decarbonization efforts.
Selio is a simple, effective and patent protected technology. The Selio prototype has been rigorously tested in the lab and in subsequent acute pre-clinical in vivo studies with very positive results.
AMT Medical BV has developed a minimal invasive medical device for heart bypass surgery. The AMT Heart Bypass System is based on the ELANA bypass, technology invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team of the UMCU. The technique is designed to make the traditional heart bypass procedures faster, safer, easier and less invasive for the patient.The product has been fully developed, production process has been designed, all pre-clinical trials have finished, a clinical multi-center trial will commence late 2019, early 2020.
Qu & Co is a developer of quantum-computational software focused on creating algorithms tailored for optimizing specialty chemicals, pharmaceuticals, and functional materials. The company's team of highly skilled quantum developers collaborates closely with clients and academic advisors to design innovative quantum algorithms and translate them into effective software solutions. Qu & Co's offerings enhance in-house discovery and optimization processes by advancing quantum-computational chemistry methods, seamlessly integrating with existing workflows in chemistry and material science. This enables clients in the pharmaceutical and other industries to conduct complex chemistry and multiphysics simulations on emerging quantum processors.
Restore Medical develops and provides a device-based therapy for congestive heart failure. It improves patient quality of life and reduce hospital readmission rates. Restore Medical's product, ContraBand, is a novel catheter-delivered implant in the pulmonary arteries for treatment of left ventricle failure, for patients with preserved right ventricle function. Restore Medical was founded in 2016 and is headquartered in Or Yehuda, Israel.
Resortecs – REcycling, SORting, TEChnologieS – is an award-winning start-up that develops Design for Disassembly solutions. We drive full circularity in the fashion industry with heat-dissolvable stitching threads and thermal disassembly systems that make industrial-scale textile recycling easy. Through targeted innovations in the way clothes are assembled and disassembled, our solutions empower fashion and workwear brands to rise to today’s environmental challenges at the pace and scale Earth needs. All without compromising the creativity, design, and quality of clothing. Resortecs' globally patented thermal disassembly solution is 5X faster than traditional disassembly methods and makes it possible to recycle up to 90% of the original fabric material: • Smart Stitich™, our heat-dissolvable stitching thread with different melting points (150 °C, 170 °C and 190 °C), enables brands to transform their products into recyclable, circular pieces from the manufacturing stage. • Smart Disassembly™, our thermal disassembly system, enables recyclers to unlock higher volumes of premium-quality material, processing up to 4M garments/year with low emissions and no material damage, so that fabrics can be used over and over again. Welcome to sustainability's next level: circularity.
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.
IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).
xFarm S.R.L. is an Italian startup established in 2017, focusing on the digitalization of agriculture. Based in Alessandria, the company designs and develops a comprehensive software-as-a-service platform tailored for farmers and stakeholders in the agrifood industry, including agronomists, dealers, cooperatives, and insurance providers. xFarm's offerings include a user-friendly agricultural application available on mobile and desktop, advanced premium modules, and an analytics dashboard for professionals. The platform is enhanced by a range of Internet of Things (IoT) sensors that are optimized and connected to support effective farm management. By providing innovative tools that address the complexities of modern agriculture, xFarm aims to simplify processes and improve operational efficiency in the agricultural sector.
Orixha has developped an innovative device for cooling patients within few minutes and thus improve their prognosis by using a dedicated liquid ventilator able to perform safe and efficient total liquid ventilation. This method consists in filling the lungs with liquid perfluorocarbons and due to the high gases solubility and the large pulmonary sufaces can use the lungs as heat exchanger.
Xelera's software makes state-of-the-art accelerator technology accessible to commercial applications in the data center and in the cloud. Due to the growing data volume and emerging demand for real-time analytics, businesses are increasingly required to build up accelerated data processing capabilities. FPGAs and GPUs will become an integral part of tomorrow’s data centers, cloud services and IoT infrastructure, powering a broad range of constantly evolving business applications. Accelerator technology can provide orders-of-magnitude acceleration to business-critical applications using Big Data analytics, machine learning, database management and to IoT infrastructures. FPGAs boost the energy efficiency of data center servers and can substantially reduce TCO.
QuantrolOx specializes in developing automated machine learning-based control software for quantum technologies, focusing on the tuning, stabilization, and optimization of qubits. By providing robust software solutions, the company aids quantum scientists in achieving stable platforms for experimentation, which enhances the effectiveness of quantum computing applications. This innovative approach allows clients to utilize more cost-effective quantum infrastructure while efficiently implementing standard quantum computing technologies in their operations.
Quanturi Oy, founded in 2016 and based in Espoo, Finland, specializes in the development and provision of continuous monitoring solutions for fermentable products, catering to the agricultural, forestry, and waste sectors. The company offers a range of wireless monitoring systems, including those for compost temperature, grain management, and hay monitoring, ensuring the safety and quality of stored materials. Its platform provides real-time alerts for potential hazards, enhancing traceability and reducing handling costs. By enabling farmers and industry professionals to monitor their products effectively, Quanturi aims to prevent business disruptions and mitigate risks associated with spoilage or accidents. The company has expanded its presence across various countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium, and sells its products online to reach a broader market.
Synergia Medical SA, founded in 2013 and based in Mont-Saint-Guibert, Belgium, specializes in the development of innovative neurostimulation medical devices. The company is focused on creating optoelectronic neurostimulators that utilize advanced materials, optical components, biosensors, and microelectronics. In particular, Synergia Medical aims to manufacture MRI-safe, implanted devices designed for treating drug-resistant epilepsy, with potential applications in other therapeutic areas. The company has achieved ISO13485 certification within a short period and has successfully developed and marketed an OEM external neurostimulator for motorized amputee prostheses. Supported by private investors and public research grants, Synergia Medical has rapidly expanded its team to include thirteen skilled professionals dedicated to advancing neurostimulation technology.
Tucuvi Care, S.L. is a Madrid-based company that specializes in developing artificial intelligence and voice technology solutions for the healthcare sector. Founded in 2019, Tucuvi's platform serves a variety of clients, including hospitals, insurance companies, telecare services, and patient associations. The company offers an intelligent virtual caregiver designed to support older adults in maintaining their independence at home. Its technology provides personalized care through features such as medication reminders, treatment guidelines, cognitive stimulation exercises, and assessments of caregiver satisfaction. Additionally, Tucuvi's platform aids healthcare professionals by enhancing their ability to monitor and care for patients, particularly those with chronic conditions like heart failure.
Oivi develops an easy and affordable AI-camera and platform that will identifies diabetic eye-disease. It allows retinal screening at primary care, creating awareness, and maintaining diabetic eye-health for all. The company has a multifaceted team with extensive knowhow on camera and software development.
Oivi was founded on 2017 and is headquartered in Oslo, Norway.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
Limula Biotech is a Swiss company specializing in the design and development of an automated system for manufacturing cell and gene therapies. The company has created a patented platform that enables the distributed production of genetically engineered cells directly at the patient's bedside, utilizing a patient's white blood cell sample. This fully closed bioreactor system minimizes human intervention during the manufacturing process while maintaining control over cell culture parameters. By facilitating on-site production in hospitals, Limula's technology aims to enhance the safety, accessibility, and efficiency of personalized gene therapies, ultimately reducing time, costs, and logistical challenges. Founded in 2018 and based in Lausanne, Switzerland, Limula Biotech is committed to revolutionizing the delivery of ex vivo gene-engineered cell therapies.
Paptic is a manufacturing company based in Espoo, Finland, established in April 2015. The company specializes in creating wood-based products that replace traditional paper and plastic, addressing the global challenge of plastic waste. Paptic's innovative bags combine the renewability and recyclability of paper with the functional benefits of plastics, providing a sustainable alternative for consumers and businesses. With a small team of ten employees, Paptic aims to contribute to a more sustainable environment while meeting the everyday needs of customers for plastic bags.
Peregrine Technologies, Inc. specializes in developing software that integrates and secures data for public safety agencies. Founded in 2017 and based in Oakland, California, the company focuses on enabling these agencies to make data-driven decisions and enhance their operations. Peregrine's technology allows for the fusion of disparate data across secure networks, providing public safety teams with tools to search, analyze, and collaborate in real-time. This software supports various initiatives, including intelligence-led policing strategies, real-time crime data analysis, community-oriented policing, and efficient management of investigations and electronic case filing.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
PhoneOptika develops innovative and state of the art technology and products that dramatically improve the user experience.
Qarnot is a company based in Montrouge, France, founded in 2010, that specializes in providing economical and ecological high-performance computing (HPC) solutions through its innovative Q.rad computing heater. This unique product combines the functionality of an electrical heater with high-performance computing capabilities, utilizing embedded microprocessors to generate heat during computation. Qarnot's computing heaters have undergone three generations of development and are marketed to construction companies for use in new buildings. By integrating computing and heating, Qarnot offers an affordable alternative to traditional data centers, significantly reducing costs associated with infrastructure, maintenance, and cooling. Users can conveniently manage the temperature of these heaters through an embedded thermostat or a smartphone application, enhancing the overall user experience.
Reactive Robotics GmbH, founded in April 2015 in Munich, Germany, specializes in the design, manufacture, and sale of rehabilitation robots aimed at facilitating early movement rehabilitation following neurological injuries and orthopedic surgeries. The company's robots are specifically tailored for gait rehabilitation in neurological patients and for use in orthopedic patients recovering from joint replacement procedures. With a team that brings over a decade of experience in rehabilitation robotics and extensive startup knowledge, Reactive Robotics has established a robust clinical network to advance its innovations. The company benefits from a diverse group of advisors who offer guidance in engineering, legal matters, and the regulatory processes necessary for medical device registration, ensuring a comprehensive approach to its operations.
Lindhe Xtend specializes in the development and sale of user-friendly prostheses and accessories aimed at enhancing the quality of life for amputees. The company's products are designed to provide a natural and flexible experience, utilizing composite materials that allow for adaptability to various terrains. By collaborating closely with users, Lindhe Xtend focuses on creating solutions that enable individuals to navigate daily challenges with ease, promoting a life of freedom and mobility.
Methinks Software, founded in 2016 and based in Barcelona, Spain, specializes in developing artificial intelligence medical software focused on stroke diagnosis and treatment. Utilizing advanced techniques from Google's deep learning framework, TensorFlow, the company analyzes neuroimaging to provide timely and accurate diagnoses of brain-related diseases, particularly acute strokes. Its medical imaging platform enables rapid assessment from non-contrast CT scans, streamlining the diagnosis process and facilitating improved communication between radiologists, hospitals, stroke units, and healthcare professionals. By bypassing the need for contrast CT scans, Methinks aims to reduce time-to-treatment, ultimately enhancing clinical outcomes and patient care in emergency settings.
Aviwell is focused on creating healthy, natural, and sustainable solutions aimed at enhancing animal health and growth, thereby contributing to global nourishment. The company operates a microbiota-based discovery platform that leverages artificial intelligence and machine learning to bridge digital and life sciences. By developing innovative food products, Aviwell seeks to provide valuable insights into animal health, growth, and performance, ultimately supporting the agri-food industry in its efforts to sustainably meet the needs of a growing population.
Developer of computing software intended to speed up the process of physical verification of integrated circuits (ICs). The company researches and creates technologies and software that integrate advanced parallel computing, accelerate machine simulations, and automate circuit verification, enabling clients to ramp up their IC design and verification process, deliver custom IP, and ensure bug-free silicon.
GlucoSet AS is a medical device company based in Trondheim, Norway, specializing in the design and manufacturing of sensor-based blood glucose monitoring tools for use in Intensive Care Units (ICUs). Founded in 2011, GlucoSet focuses on developing intravascular sensor technology that provides continuous and accurate monitoring of blood glucose levels in critically ill patients. This technology addresses the challenges of elevated and unstable glucose levels in ICU settings, which can lead to costly complications, prolonged hospital stays, and increased mortality rates. By delivering real-time glucose information, GlucoSet's system enables healthcare professionals to effectively manage glucose levels, thereby minimizing the risk of harmful hypoglycemia and improving overall patient outcomes.
Indoor Robotics Ltd, founded in 2018 and based in Ramat Gan, Israel, specializes in the design and development of Tando, an AI-powered patrol drone tailored for indoor security and inspection purposes. The company leverages artificial intelligence to create an autonomous indoor intelligence platform that enhances decision-making and reduces errors. Tando is capable of conducting security patrols, inspecting facilities, and identifying irregularities such as leaks and fire hazards. Additionally, the drone learns its environment and adapts its responses to various detected anomalies, thus improving area coverage and response times for users.
Paptic is a manufacturing company based in Espoo, Finland, established in April 2015. The company specializes in creating wood-based products that replace traditional paper and plastic, addressing the global challenge of plastic waste. Paptic's innovative bags combine the renewability and recyclability of paper with the functional benefits of plastics, providing a sustainable alternative for consumers and businesses. With a small team of ten employees, Paptic aims to contribute to a more sustainable environment while meeting the everyday needs of customers for plastic bags.
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.
QuantWare engages in designing, developing, and fabricating hardware to enable quantum computing.
Loci Orthopaedics Limited is a medical technology company based in Upper Newcastle, Ireland, focused on developing innovative solutions for orthopedic care. Established in 2017, the company specializes in the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, providing a less invasive and easier insertion method compared to existing surgical options. Loci Orthopaedics also emphasizes evidence-based designs in its products, aiming to address significant unmet clinical needs in orthopedic extremities.
Loci Orthopaedics Limited is a medical technology company based in Upper Newcastle, Ireland, focused on developing innovative solutions for orthopedic care. Established in 2017, the company specializes in the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, providing a less invasive and easier insertion method compared to existing surgical options. Loci Orthopaedics also emphasizes evidence-based designs in its products, aiming to address significant unmet clinical needs in orthopedic extremities.
Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel.
Osteoarthritis is the 4th leading cause of mobility associated disability and affects more than 100 million patients in the Western world, who are all in need for an effective treatment.
It is the aim of Hy2Care to change the future for patients suffering from osteoarthritis.
Miraex SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in the development and manufacturing of photonic and quantum solutions. The company focuses on creating advanced photonic sensors, quantum transducers, and quantum converters aimed at enhancing industrial applications, aerospace security, and defense, as well as quantum networking and computing. Miraex's innovative systems are designed to operate in challenging environments where traditional electronic sensors are ineffective, allowing for proactive asset failure prevention. Additionally, the company constructs quantum integrated circuits tailored for high-sensitivity measurements and supports the infrastructure necessary for distributed quantum computing.
Piomic is a developer of a portable, hand-held medical device designed to treat chronic wounds, specifically targeting chronic leg and foot ulcers. The device utilizes optical and magnetic stimulation technologies to promote wound healing, aiming to alleviate the significant burden posed by the estimated 50 million patients suffering from hard-to-heal wounds globally. Clinical studies have demonstrated that the treatment is safe, accelerates wound closure, reduces pain, and enhances the overall quality of life for patients. The device features a simple, single-button operation, allowing for seamless integration into various healthcare settings, including stationary facilities, ambulatory care, and home use. Through its innovative approach, Piomic seeks to improve patient outcomes and provide a more effective solution for managing chronic wounds.
Neurosoft Bioelectronics specializes in the development of soft implantable electrodes designed to interface with the nervous system for diagnosing and treating neurological disorders. Based in Geneva, Switzerland, the company has created next-generation electrodes that are compliant and conformable, addressing the limitations of existing stiff devices. Their flagship product, SOFT ECoG, is a subdural electrode that records from and stimulates the brain's surface, enhancing recording quality and minimizing MRI artifacts. Neurosoft's technology promotes long-term bio-integration, adapting to both static and dynamic mechanics of neural tissue, which can improve therapeutic outcomes for patients and expand the applications of neural interfaces in clinical settings.
Oxara AG, founded in 2018 and based in Zurich, Switzerland, specializes in sustainable building products aimed at addressing challenges in the construction industry. The company focuses on the circular economy by utilizing locally available landfill waste, such as excavation materials, to produce a unique poured earth concrete. This innovative material retains the advantages of traditional concrete while being significantly cheaper and 90% more environmentally friendly. Oxara offers a range of products, including additives and branded materials like Oxacrete, Oxaflow, Oxabrick, Cleancrete, Cleanflow, and Cleanbrick. The company is committed to fostering a global community dedicated to sustainable construction and affordable housing solutions, prioritizing the needs of its employees and clients.
OxyPrem AG is a Swiss company that develops, designs, and manufactures advanced sensor solutions specifically for monitoring preterm infants. Founded in 2018 and based in Zurich, it offers a reusable oxygen sensor that continuously measures hemoglobin oxygen saturation in any human tissue, particularly focusing on the brains of high-risk preterm infants. By employing noninvasive near-infrared light technology, the device provides real-time monitoring, enabling healthcare professionals to prevent severe outcomes such as early death or long-term brain damage in this vulnerable population. OxyPrem's innovative approach not only enhances clinical care but also significantly reduces medical waste associated with single-use devices.
Artiria Medical SA develops micro-actuated device to treat vascular diseases. Its products bring micromotion deep in the brain arteries, enabling a navigation and stroke treatment. It empowers catheters and guidewires. Artiria Medical SA was incorporated in 2019 and is based in Lausanne, Switzerland.
Avantama is a leading developer of nanomaterials specifically tailored for electronic applications. The company specializes in nanoparticle dispersions and formulations, offering a range of services including joint development, contract licensing, and customized compositions. Avantama's innovative material technologies facilitate the creation of high-quality optical and electronic coatings using established printing and coating techniques. With a production capacity at the multi-ton scale and adherence to high industry standards, Avantama supports various applications such as displays, OLEDs, Quantum Dot Displays, and solution-processed organic photovoltaics. This capability not only enhances product development but also accelerates time-to-market for its clients, positioning Avantama as a preferred partner for future innovations in the electronics sector.
Nuclidium’s vision is to address the unmet need to detect and stage cancer more accurately so that treatment options for cancer patients and their long-term survival can be significantly improved.
Swiss Airtainer has developed a temperature-controlled container for the transport of pharmaceutical products by air.
Gr3n invented a new process which allows for the first time to recycle PET bottles/food containers chemically in a profitable way. Gr3n developed an innovative process, based on a new application of microwave technology to a well known chemical reaction which provides for the first time with an economically efficient chemical recycling process of PET (Polyethylene Terephtalate) and allows an industrial implementation of this recycling method. This new process can potentially change how PET is recycled worldwide with a huge financial benefit for the recycling industry.
Plair SA develops and manufactures systems for preventive environment monitoring. It offers Rapid-E, an instrument that accurately and comprehensively analyze single aerosol particles in real time; and Rapid-C uses laser-induced fluorescence and light scattering detection, providing unprecedented high-level output in particle counts. The company was founded in 2014 and is based in Plan-les-Ouates, Switzerland.
embotech AG specializes in developing decision-making software solutions for autonomous systems. Founded in 2013 as a spin-off from the Automatic Control Laboratory at ETH Zurich, the company provides FORCES Pro, a numerical optimization software that enables the design of complex control systems. This software is utilized in various applications, including the control of wind turbines, planning the collision-free motion of autonomous drones, and the development of advanced driver assistance systems. Additionally, it supports precision landing of spacecraft on other planets and the recovery of reusable rockets. Embotech's solutions cater to sectors such as automotive, energy, and robotics, aiming to enhance safety, productivity, and energy efficiency in automated decision-making processes. The company is headquartered in Zurich, Switzerland.
KOVE is a medical device company.
Legacy Healthcare is a biopharma company focused on the development of oncology supportive care and dermatology drugs
DePoly is a spin off out of the LSMO lab at EPFL- Valais that has developed a novel technology allowing for the chemical recycling of PET plastic back to its main two components ethylene glycol (EG) and terephthalic acid (TPA). Our approach turns low valued materials (PET waste) into high-valued chemicals like TPA creating a circular economy. We expect this process to generate revenue from chemically recycling PET to TPA/EG, which can be sold back to industry to make new virgin PET plastic and allowing for a sustainable source of TPA and EG on the market.
Dimpora AG, based in Zürich, Switzerland, specializes in the design and manufacture of eco-friendly waterproof membranes for the outdoor textile industry. The company produces functional membranes that are primarily composed of polyurethane and utilize a unique template removal method to achieve breathability while maintaining water resistance. Dimpora's innovative technology allows for the direct application of membranes onto various 3D surfaces, enabling fast sweat transport and complete protection from rain. Committed to sustainability, Dimpora aims to develop next-generation high-performance membranes that enhance outdoor experiences without compromising environmental integrity. The company focuses on creating products that not only perform well but also prioritize the use of recyclable materials, aligning with its vision of promoting responsible enjoyment of nature.
Lumiphase develops novel optical communication chips that are very inexpensive, super compact, and highly efficient.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.
Nuventura GmbH, founded in 2017 and based in Berlin, Germany, specializes in the design and development of gas-insulated switchgear (GIS) technology. The company focuses on creating innovative switchgear solutions that replace sulfur hexafluoride (SF6) with dry air, significantly reducing the use of greenhouse gases in the energy supply sector. Nuventura's technology maintains the benefits of traditional SF6 switchgear while adhering to existing IEC standards, allowing industries to effectively control, protect, and isolate electrical equipment. This approach facilitates improved monitoring of switchgear health and addresses environmental concerns associated with greenhouse gas emissions.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
PeekMed is a 3D pre-operative planning system for orthopedic surgery that aims to help the surgeon better treat the patient while reducing costs. With PeekMed the surgeon can plan: - Total Joint Replacements; - Osteotomies; - Fracture reductions; - Virtually any orthopedic procedure. The output of PeekMed system can later be used as an input for: - Navigation systems; - 3D printers; - Robotics; - Mobile devices. PeekMed was founded by Jaime Campos, Sara Silva, and João Pedro Ribeiro in 2015 and is located in Braga, Portugal.
AdjuCor is a high-tech medical device company that owns and is responsible for development, production, marketing and selling of a revolutionary technology for the treatment of end-stage heart failure patients. Its flagship product is called BEAT. The market introduction of BEAT will be the world’s first commercially available, minimal invasive application of mechanical circulatory support for the failing heart. It provides uni- or biventricular support, while also completely avoiding contact with blood. This unique feature set will allow for the transformation of standard-of-care treatment in end-stage heart failure, as well as greatly expand treatment to previously unreached patients.
Dracula Technologies SAS specializes in the design and manufacture of organic photovoltaic cells aimed at providing energy autonomy for connected devices. Founded in 2011 and based in Valence, France, the company develops products that enable small electronic devices, such as phones, GPS units, and lamps, to self-recharge using solar energy. Their flagship product, Light As Your Energetic Response (LAYER), is designed to capture various forms of light, both indoors and outdoors, and convert it into usable energy through advanced digital printing techniques. The team consists of approximately 20 members, including a scientific committee and an administrative committee, all dedicated to fostering innovation and collaboration within the company. Dracula Technologies operates as a subsidiary of Ardeje.
Ignion is an antenna innovator that creates a multiband, multipurpose and ready-to-use antenna. The company was founded in 2015 and is based in Sant Cugat del Vallès, Spain.
Saalg Geomechanics is owner and operator of an engineering company intended to offer specialized advanced geological and numerical services. The company offers numerical model calibrations and soil and rock parameters characterization by backanalysis and inverse analysis, 2D and 3D geomechanical and geotechnical simulations, manily for TBM Tunnel Excavations, Conventional Tunnels, Large and deep excavations, reinforced earth retaining walls and wellbore stabity analysis, enabling their customers to build a bridge between academic research in the field of geomechanics and the industry.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
Surgify Medical Oy, founded in 2015 and based in Espoo, Finland, specializes in developing innovative surgical technology aimed at enhancing safety during bone surgeries. The company's flagship product is a neurological burr designed to prevent injuries to nerves and blood vessels, which can occur with traditional surgical drills. This technology is compatible with existing surgical equipment, eliminating the need for additional training for medical personnel. Surgify's solutions have applications in orthopedics and dentistry and are being commercialized in collaboration with Aalto University, with financial support from Tekes, the Finnish Funding Agency for Innovation. The company has also established a partnership with the Neurosurgical Department of Helsinki University Central Hospital to facilitate ongoing communication with clinicians, ensuring that its technology effectively meets the needs of healthcare providers and improves patient outcomes by reducing complications such as bleeding and infections.
CH-Bioforce provides a revolutionary technology for converting all biomass components into high-value material streams - dissolving pulp, polymeric hemicellulose, and sulphur-free lignin. These valuable biomaterials can replace fossil and food-based raw materials in multiple industries, such as textiles and packaging applications.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
PrediSurge is a software company that offers design and support solutions for physicians and medical device companies.
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, focused on developing genetically modified oncolytic viruses to improve cancer treatments. Established in 2013, the company aims to enhance tumor T-cell therapies through its patented technology, which utilizes oncolytic viruses to modify the tumor microenvironment and counteract its immune-suppressive properties. TILT Biotherapeutics is advancing several product candidates, including TILT-123, TILT-234, and TILT-321, and plans to translate its innovative approach into clinical trials. The technology is designed to bolster the effectiveness of tumor-infiltrating lymphocyte (TIL) therapies, chimeric antigen receptor (CAR-T) therapies, and checkpoint inhibitors, potentially achieving outcomes in solid tumors similar to those seen in hematological cancers.